Erle S Robertson Selected Research

Erle S Robertson Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 03/2002
16	Infections 01/2022 - 06/2004
12	Neoplasm Metastasis (Metastasis) 12/2021 - 08/2005
9	Carcinogenesis 01/2022 - 01/2006
8	Hypoxia (Hypoxemia) 12/2021 - 08/2006
8	Lymphoma (Lymphomas) 07/2021 - 07/2009
6	Latent Infection 01/2015 - 03/2005
6	Kaposi Sarcoma (Kaposi's Sarcoma) 06/2014 - 03/2005
5	Chromosomal Instability (Chromosome Stability) 01/2019 - 01/2006
4	Epstein-Barr Virus Infections 01/2022 - 05/2009
4	Virus Diseases (Viral Diseases) 12/2021 - 01/2016
4	Hematologic Neoplasms (Hematological Malignancy) 12/2020 - 01/2013
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 09/2005
3	Primary Effusion Lymphoma 06/2014 - 11/2006
2	Breast Neoplasms (Breast Cancer) 11/2020 - 09/2002
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2021
1	Thrombocytopenia (Thrombopenia) 08/2021
1	Thrombophilia 08/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Triple Negative Breast Neoplasms 11/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 05/2017
1	Zygomycosis (Phycomycosis) 01/2016
1	Persistent Infection 12/2015
1	Herpes Zoster 04/2015
1	Leukemia 08/2014
1	Aneuploidy (Aneuploid) 11/2013

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2005
18	latency-associated nuclear antigenIBA 12/2021 - 06/2004
8	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 03/2011
8	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 05/2008
7	AntigensIBA 01/2022 - 10/2006
5	UbiquitinIBA 01/2022 - 10/2006
4	Protein Isoforms (Isoforms)IBA 12/2020 - 10/2011
4	Biological ProductsIBA 12/2020 - 03/2005
4	Phosphotransferases (Kinase)IBA 08/2014 - 05/2008
3	SurvivinIBA 07/2021 - 07/2009
3	Histones (Histone)IBA 06/2020 - 12/2014
3	Viral AntigensIBA 12/2015 - 02/2015
3	Epstein-Barr Virus Nuclear AntigensIBA 04/2015 - 09/2002
3	ChromatinIBA 01/2015 - 06/2014
2	RNA (Ribonucleic Acid)IBA 12/2021 - 09/2014
2	Messenger RNA (mRNA)IBA 08/2021 - 01/2011
2	QuassinsIBA 12/2020 - 01/2020
2	brusatolIBA 12/2020 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 05/2009
2	Cyclin D1IBA 01/2019 - 02/2011
2	CytokinesIBA 01/2019 - 01/2012
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 01/2018
2	CyclinsIBA 02/2016 - 03/2005
2	Cadherins (E-Cadherin)IBA 01/2016 - 04/2015
2	Transcription Factors (Transcription Factor)IBA 04/2015 - 07/2006
2	Small Interfering RNA (siRNA)IBA 12/2011 - 11/2006
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2010 - 05/2009
2	Viral ProteinsIBA 01/2009 - 03/2005
2	GuanineIBA 08/2008 - 08/2005
2	epstein-barr virus EBNA-3CIBA 07/2006 - 08/2005
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	COVID-19 VaccinesIBA 08/2021
1	Antiphospholipid AntibodiesIBA 08/2021
1	Mutant Proteins (Protein, Mutant)IBA 04/2021
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 04/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2021
1	Fatty Acid-Binding ProteinsIBA 01/2021
1	Vascular Endothelial Growth FactorsIBA 11/2020
1	VaccinesIBA 09/2020
1	Proteasome InhibitorsIBA 01/2020
1	Untranslated RNA (Noncoding RNA)IBA 01/2020
1	Cyclin EIBA 01/2019
1	6-methyladenineIBA 01/2019
1	Protein AggregatesIBA 01/2018
1	Lactate Dehydrogenase 5IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	TransferasesIBA 01/2018
1	Cyclin D2IBA 01/2018
1	E2F Transcription FactorsIBA 01/2016
1	Histocompatibility Antigens Class IIIBA 01/2016
1	Dinoprostone (PGE2)FDA Link 10/2015
1	Cell Adhesion MoleculesIBA 04/2015
1	CateninsIBA 04/2015
1	VimentinIBA 04/2015
1	Growth InhibitorsIBA 02/2015
1	histone H3 trimethyl Lys4IBA 12/2014
1	ParaffinIBA 09/2014
1	Formaldehyde (Formol)FDA Link 09/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2014
1	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 08/2014
1	A-Form DNA (A-DNA)IBA 06/2014
1	Butyric Acid (Butanoic Acid)IBA 06/2014
1	Aurora Kinase BIBA 11/2013
1	Serine (L-Serine)FDA Link 05/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Aurora Kinase AIBA 01/2012
1	Trans-Activators (Trans-Acting Factor)IBA 07/2011

Therapy/Procedure

15	Therapeutics 12/2020 - 09/2005
1	Immunotherapy 09/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2020
1	Neck Dissection (Radical Neck Dissection) 01/2020